Randomized Clinical and Radiographic Study

September 23, 2024 updated by: Banan Lotfy Mohamed Amer, Tanta University

Evaluation of Autogenous Dentin Graft Versus Demineralized Freeze-Dried Bone Allograft in the Treatment of Class ΙΙ and ΙΙΙ Mandibular Furcation Defects

Randomized clinical and radiographic trial

Study Overview

Status

Completed

Detailed Description

Evaluation of Autogenous Dentin Graft versus Demineralized Freeze-Dried Bone Allograft in the Treatment of Class ΙΙ and ΙΙΙ Mandibular Furcation Defects

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tanta, Egypt
        • Faculty of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

-

Presence of class II and/or ΙΙΙ furcation defects in mandibular first or second molars according to criteria outlined by Hamp et. al. 1975.

  • Horizontal probing depth ≥3 mm using Naber's probe.
  • Clinical attachment level ≥3 mm measured from cemento-enamel junction (CEJ) till the deepest probing depth.
  • Evidence of radiolucency in the furcation area on panoramic radiograph.
  • Patients who will be assigned for groups (I and II) should present with teeth required for extraction due to advanced periodontal bone loss or other indications such as hopeless wisdom teeth or orthodontic indications or unrestorable fractured teeth as a source for autogenous dentin graft (ADG).

Exclusion Criteria:

  • Medically compromised patients and systemic conditions precluding periodontal surgery.

    • Mandibular first or second molars with root caries or endodontic treatment.
    • Smokers, diabetics, pregnant or lactating women.
    • History of chemotherapy, radiotherapy in head and/or neck region.
    • Bisphosphonate therapy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1 subgroup A
Grade II furcation involvement treated with autogenous dentin graft
Randomized clinical and radiographic trial
Experimental: Group 1 Subgroup B
Grade II furcation involvement treated with demineralized freeze-dried bone allograft
Randomized clinical and radiographic trial
Experimental: Group II subgroup A
Grade III furcation involvement treated with Autogenous dentin graft
Randomized clinical and radiographic trial
Experimental: Group II subgroup B
Grade III furcation involvement treated with demineralized freeze-dried bone allograft
Randomized clinical and radiographic trial

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Probing pocket depth
Time Frame: Measured at baseline, 6 months and 12 months
According to Ramfjord, clinical parameter measured by UNC periodontal probe from a fixed point to the deepest probing depth. Using stent to standardize the measurements.
Measured at baseline, 6 months and 12 months
Clinical attachment level
Time Frame: Measured at baseline, 6 months and 12 months
According to Ramfjord, clinical parameter measured by a Naber's probe. Using stent to standard measurements.
Measured at baseline, 6 months and 12 months
Bleeding on probing
Time Frame: Measured at baseline, 6 months and 12 months
According to Ramfjord, the bleeding at each site observed after probing and recorded positive if bleeding was observed within 30 seconds, if not was recorded as negative.
Measured at baseline, 6 months and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiographic outcome
Time Frame: measured at baseline and 1 year follow up
Using CBCT software to analyse furcation volume
measured at baseline and 1 year follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Banan L Amer, Master, Tanta University
  • Study Director: Samia A Darwish, Professor, Tanta University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2021

Primary Completion (Actual)

December 12, 2023

Study Completion (Actual)

December 30, 2023

Study Registration Dates

First Submitted

December 5, 2023

First Submitted That Met QC Criteria

September 23, 2024

First Posted (Actual)

September 24, 2024

Study Record Updates

Last Update Posted (Actual)

September 24, 2024

Last Update Submitted That Met QC Criteria

September 23, 2024

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • OMPDR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autogenous Dentin Graft

Clinical Trials on (guided tissue regeneration)

Subscribe